Elranatamab plus intrathecal therapy sustains CNS remission in myeloma
In a remarkable case that could reshape how oncologists approach one of blood cancer's most feared complications, physicians in Türkiye ...
In a remarkable case that could reshape how oncologists approach one of blood cancer's most feared complications, physicians in Türkiye ...
In a groundbreaking advancement poised to revolutionize the treatment landscape of brain tumors, researchers have unveiled a novel therapeutic strategy ...
In a groundbreaking development within oncology and neuro-oncology, researchers have unveiled compelling evidence positioning hepcidin as a potent biomarker for ...
Glioblastoma remains one of the most formidable and aggressive brain cancers faced by modern medicine. Characterized by rapid growth and ...
In a compelling advancement in neuro-oncology, researchers from the University of Cologne have uncovered critical insights into the molecular mechanisms ...
In the relentless quest to improve diagnostic precision for complex brain malignancies, a groundbreaking study published in BMC Cancer unveils ...
In the relentless battle against glioblastoma, one of the most aggressive and lethal brain cancers, medical science has faced formidable ...
Glioblastoma (GBM), a formidable adversary in neuro-oncology, stands as the most aggressive and common primary brain tumor, originating from glial ...
Researchers at Moffitt Cancer Center have secured a monumental $22.4 million grant from the U.S. Department of War to ignite ...
In a groundbreaking advancement for neuro-oncology, researchers have unveiled a novel predictive model capable of determining the consistency of pituitary ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine